| Eli Lilly & Co. | 6.81% | Other/Unclassified (no country filed) |
|---|
| AbbVie, Inc. | 6.58% | Other/Unclassified (no country filed) |
|---|
| Johnson & Johnson | 6.20% | Other/Unclassified (no country filed) |
|---|
| UnitedHealth Group, Inc. | 5.83% | Other/Unclassified (no country filed) |
|---|
| AstraZeneca plc | 4.57% | Other/Unclassified (no country filed) |
|---|
| Merck & Co., Inc. | 4.21% | Other/Unclassified (no country filed) |
|---|
| Bristol-Myers Squibb Co. | 3.50% | Other/Unclassified (no country filed) |
|---|
| Thermo Fisher Scientific, Inc. | 3.19% | Other/Unclassified (no country filed) |
|---|
| Intuitive Surgical, Inc. | 2.96% | Other/Unclassified (no country filed) |
|---|
| CVS Health Corp. | 2.71% | Other/Unclassified (no country filed) |
|---|
| Novo Nordisk A/S | 2.65% | Other/Unclassified (no country filed) |
|---|
| Roche Holding AG | 2.65% | Other/Unclassified (no country filed) |
|---|
| Hoya Corp. | 2.35% | Other/Unclassified (no country filed) |
|---|
| Regeneron Pharmaceuticals, Inc. | 2.19% | Other/Unclassified (no country filed) |
|---|
| Boston Scientific Corp. | 2.04% | Other/Unclassified (no country filed) |
|---|
| UCB SA | 1.97% | Other/Unclassified (no country filed) |
|---|
| Vertex Pharmaceuticals, Inc. | 1.96% | Other/Unclassified (no country filed) |
|---|
| Danaher Corp. | 1.90% | Other/Unclassified (no country filed) |
|---|
| Edwards Lifesciences Corp. | 1.83% | Other/Unclassified (no country filed) |
|---|
| McKesson Corp. | 1.78% | Other/Unclassified (no country filed) |
|---|
| Stryker Corp. | 1.59% | Other/Unclassified (no country filed) |
|---|
| Argenx SE | 1.54% | Other/Unclassified (no country filed) |
|---|
| Teva Pharmaceutical Industries Ltd. | 1.41% | Other/Unclassified (no country filed) |
|---|
| Cardinal Health, Inc. | 1.38% | Other/Unclassified (no country filed) |
|---|
| Centene Corp. | 1.32% | Other/Unclassified (no country filed) |
|---|
| Biogen, Inc. | 1.30% | Other/Unclassified (no country filed) |
|---|
| Zoetis, Inc. | 1.17% | Other/Unclassified (no country filed) |
|---|
| United Therapeutics Corp. | 1.16% | Other/Unclassified (no country filed) |
|---|
| Lonza Group AG | 1.11% | Other/Unclassified (no country filed) |
|---|
| Novartis AG | 1.04% | Other/Unclassified (no country filed) |
|---|
| Fresenius SE & Co. KGaA | 1.04% | Other/Unclassified (no country filed) |
|---|
| IQVIA Holdings, Inc. | 1.03% | Other/Unclassified (no country filed) |
|---|
| Sartorius AG | 0.91% | Other/Unclassified (no country filed) |
|---|
| Spyre Therapeutics, Inc. | 0.89% | Other/Unclassified (no country filed) |
|---|
| Apogee Therapeutics, Inc. | 0.86% | Other/Unclassified (no country filed) |
|---|
| Ionis Pharmaceuticals, Inc. | 0.84% | Other/Unclassified (no country filed) |
|---|
| Argenx SE | 0.82% | Other/Unclassified (no country filed) |
|---|
| CG oncology, Inc. | 0.78% | Other/Unclassified (no country filed) |
|---|
| Ascendis Pharma A/S | 0.71% | Other/Unclassified (no country filed) |
|---|
| Align Technology, Inc. | 0.69% | Other/Unclassified (no country filed) |
|---|
| Immunome, Inc. | 0.69% | Other/Unclassified (no country filed) |
|---|
| Dyne Therapeutics, Inc. | 0.67% | Other/Unclassified (no country filed) |
|---|
| JPMorgan Securities Lending Money Market Fund | 0.64% | Other/Unclassified (no country filed) |
|---|
| Dexcom, Inc. | 0.64% | Other/Unclassified (no country filed) |
|---|
| Neurocrine Biosciences, Inc. | 0.63% | Other/Unclassified (no country filed) |
|---|
| Genmab A/S | 0.63% | Other/Unclassified (no country filed) |
|---|
| Daiichi Sankyo Co. Ltd. | 0.61% | Other/Unclassified (no country filed) |
|---|
| Convatec Group plc | 0.61% | Other/Unclassified (no country filed) |
|---|
| Cigna Group (The) | 0.60% | Other/Unclassified (no country filed) |
|---|
| Medtronic plc | 0.59% | Other/Unclassified (no country filed) |
|---|
| Alumis, Inc. | 0.54% | Other/Unclassified (no country filed) |
|---|
| Nuvalent, Inc. | 0.53% | Other/Unclassified (no country filed) |
|---|
| Bio-Techne Corp. | 0.42% | Other/Unclassified (no country filed) |
|---|
| Sionna Therapeutics, Inc. | 0.42% | Other/Unclassified (no country filed) |
|---|
| Disc Medicine, Inc. | 0.38% | Other/Unclassified (no country filed) |
|---|
| Alnylam Pharmaceuticals, Inc. | 0.31% | Other/Unclassified (no country filed) |
|---|
| Viridian Therapeutics, Inc. | 0.28% | Other/Unclassified (no country filed) |
|---|
| Evommune, Inc. | 0.27% | Other/Unclassified (no country filed) |
|---|
| Xenon Pharmaceuticals, Inc. | 0.27% | Other/Unclassified (no country filed) |
|---|
| HCA Healthcare, Inc. | 0.27% | Other/Unclassified (no country filed) |
|---|
| Genmab A/S | 0.12% | Other/Unclassified (no country filed) |
|---|
| Swiss Franc | 0.00% | Other/Unclassified (no country filed) |
|---|
| Danish Krone | 0.00% | Other/Unclassified (no country filed) |
|---|
| Japanese Yen | -0.00% | Other/Unclassified (no country filed) |
|---|
| British Pound | -0.00% | Other/Unclassified (no country filed) |
|---|
| EURO | -0.00% | Other/Unclassified (no country filed) |
|---|